United Capital Financial Advisers, LLC Sangamo Therapeutics, Inc Transaction History

United Capital Financial Advisers, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $86,561 - $129,428	-16,551 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $36 - $54	5 Added 0.03%	16,551 $124,000
Q2 2021 Aug 13, 2021	SELL	$10.17 - $12.64 $101 - $126	-10 Reduced 0.06%	16,546 $198,000
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $21,324 - $33,418	-1,960 Reduced 10.59%	16,556 $207,000
Q4 2020 Feb 17, 2021	SELL	$9.23 - $18.18 $177,520 - $349,655	-19,233 Reduced 50.95%	18,516 $289,000
Q3 2020 Nov 13, 2020	SELL	$9.38 - $12.48 $93,771 - $124,762	-9,997 Reduced 20.94%	37,749 $357,000
Q2 2020 Aug 13, 2020	SELL	$6.21 - $11.83 $252,933 - $481,835	-40,730 Reduced 46.04%	47,746 $428,000
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $505 - $885	100 Added 0.11%	88,476 $564,000
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $115,888 - $168,854	14,432 Added 19.52%	88,376 $740,000
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $905 - $1,222	-100 Reduced 0.14%	73,944 $669,000
Q2 2019 Aug 13, 2019	BUY	$8.75 - $13.03 $356,387 - $530,711	40,730 Added 122.26%	74,044 $797,000
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $9,510 - $16,600	1,000 Added 3.09%	33,314 $382,000
Q4 2017 Feb 13, 2018	BUY	$11.6 - $17.35 $1,160 - $1,735	100 Added 0.31%	32,314 $530,000
Q2 2017 Aug 14, 2017	BUY	N/A	32,214	32,214 $283,000

113

57.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $178M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.